Alabama Litigation Review

Alabama Litigation Review

Insights & Commentary on Developments in Alabama Litigation

Tag Archives: medical device

Injury Cases Involving Atrium C-Qur Hernia Mesh Continue To Progress

Posted in Defective Products
At the Blackwell Law Firm website we have a section called Hot Topics. That section provides news and research related to current legal issues. Many of these issues involve injury from bad drugs or dangerous medical devices. Among those topics — two hernia mesh products. These are Ethicon’s Physiomesh and Atrium’s C-Qur mesh. We are currently… Continue Reading

Were Clinical Trials For Xarelto Tainted By Misconduct?

Posted in Defective Products, Personal Injury
What is Xarelto? Xarelto (Rivaroxaban) is a relatively new anticoagulant (blood thinner). The FDA first approved Xarelto in 2011. It is distributed in the United States by Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer Healthcare. Xarelto was released as a replacement for Coumadin (Warfarin), a blood thinner effectively used for decades. Xarelto is used… Continue Reading

Boston Scientific Suffers Another Trial Loss Over A Mesh Product

Posted in Defective Products, Federal Courts, Personal Injury
Last week, a Federal Court jury in Florida found Boston Scientific liable for the severe personal injuries caused by one of its transvaginal mesh products. The Florida case involved four women suffering tremendous problems from implanted mesh. The jury assessed $26.7 Million in damages against the company. This was not the first trial loss suffered by… Continue Reading

Mesh: Concerns and Questions

Posted in Defective Products
Transvaginal mesh and its complications made headlines this week as a jury reached a $3.35 million compensatory damages verdict in a New Jersey Court, with punitive damages to follow. This bold action ignites concern and questions for thousands of other women implanted with the same device. What is transvaginal mesh? Transvaginal mesh is a medical… Continue Reading

Alabama Will Receive Share of Record Drug Company Fine

Posted in Defective Products, Personal Injury
Drug maker GlaxoSmithKline (Glaxo) will pay a record $3 Billion criminal fraud settlement with the government as a result of its deceptive sales practices. The criminal charges accused Glaxo of practices which pushed dangerous medications on the American public. According to the news, the State of Alabama will receive almost $6 Million of the proceeds.… Continue Reading

Update — Consolidation of Defective Mesh Claims Against Boston Scientific

Posted in Defective Products
A couple weeks ago, the U.S. Judicial Panel on Multidistrict Litigation (JPML) met in Miami to discuss the consolidation of claims against several transvaginal mesh manufacturers. I previously wrote about this issue. Today, the JPML issued its decision. As requested by many of the plaintiffs, the Court has consolidated the pre-trial proceedings in the Southern… Continue Reading

Can the Heart Medication MULTAQ Cause Severe Liver Injury

Posted in Defective Products
Atrial fibrillation is a huge health issue affecting many individuals.  It is estimated that this condition affects 2.3 million Americans.  At present, the FDA has approved a variety of treatments. In 2009, the drug company Sanofi-Aventis began to market dronedarone under the brand name Multaq as an additional medication for atrial fibrillation.  Although the FDA… Continue Reading

Depuy Hip Replacement Implants and the Influence of Medical Device Manufacturers over Physicians

Posted in Defective Products
Last month I discussed the recent recall of the ASR hip replacement products manufactured by Depuy Orthopedics.  With over 90,000 of these medical implants sold, this is a tremendous issue that will affect many people.  These defective implants can result in significant injuries and damages to the individuals using them.  How will Depuy treat the patients who underwent these… Continue Reading